Real-World Safety and Effectiveness of Sotyktu (Deucravacitinib) in Patients With Moderate-to-Severe Plaque Psoriasis in Korea
Clinical trial NCT06258668 · RECRUITING
Trial details
- NCT number
- NCT06258668
- Sponsor
- Bristol-Myers Squibb
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-08-21
- Primary completion
- 2028-09-30
- Enrollment
- 505
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.